Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis

Not Applicable

Recruiting

Conditions: Adenomyosis

Interventions: Procedure: Uterine artery embolization
Procedure: Intrauterine device

First Posted Date: 2023-09-21

Last Posted Date: 2023-09-21

Lead Sponsor: Yonsei University

Target Recruit Count: 56

Registration Number: NCT06043583

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Benfit of Remote Monitoring in Pacemaker

Not Applicable

Recruiting

Conditions: Pacemaker Implanted Patients

Interventions: Device: Remote Monitoring arm

First Posted Date: 2023-09-21

Last Posted Date: 2023-09-21

Lead Sponsor: Yonsei University

Target Recruit Count: 900

Registration Number: NCT06043570

Locations: 🇰🇷
Severance Cardiovascular Hospital Yonsei University, Seoul, Korea, Republic of

Dexmedetomidine Infusion During Laparoscopic Adrenalectomy

Not Applicable

Completed

Conditions: Pheochromocytoma

Interventions: Drug: 0.9% normal saline
Drug: dexmedetomidine

First Posted Date: 2023-09-14

Last Posted Date: 2023-10-06

Lead Sponsor: Yonsei University

Target Recruit Count: 40

Registration Number: NCT06037135

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Phase 2

Recruiting

Conditions: Uterine Cervical Neoplasms
Vulvar Cancer
Vagina Neoplasm
Ovarian Neoplasms
Endometrial Neoplasms
Clear Cell Carcinoma

Interventions: Drug: Doxorubicin
Drug: Dostarlimab
Drug: Bevacizumab
Drug: Gemcitabine
Drug: Paclitaxel
Drug: Pegylated liposomal doxorubicin

First Posted Date: 2023-09-05

Last Posted Date: 2024-07-23

Lead Sponsor: Yonsei University

Target Recruit Count: 198

Registration Number: NCT06023862

Locations: 🇰🇷
Bundang Seoul National University Hospital, Seongnam-si, Korea, Republic of
🇰🇷
Severance Hospital, Yonsei Health System, Seoul, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

and more 5 locations

Lazertinib and Chemotherapy Combination in EGFR-mutant NSCLC Patients Without ctDNA Clearance After lead-in Lazertinib Monotherapy

Phase 2

Not yet recruiting

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Lazertinib
Drug: Lazertinib+Pemetrexed+Carboplatin

First Posted Date: 2023-09-01

Last Posted Date: 2023-09-01

Lead Sponsor: Yonsei University

Target Recruit Count: 129

Registration Number: NCT06020989

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Effect of Preoperative Rectus Sheath Block on Quality of Recovery in Single Port Laparoscopic Adnexal Surgery

Not Applicable

Not yet recruiting

Conditions: Single Port Laparoscopic Adnexal Surgery

Interventions: Drug: Ultrasound guided rectus sheath block with normal saline
Drug: Ultrasound guided rectus sheath block with dexmedetomidine

First Posted Date: 2023-08-09

Last Posted Date: 2023-08-09

Lead Sponsor: Yonsei University

Target Recruit Count: 56

Registration Number: NCT05984212

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Exploration of Clonal Hematopoiesis of Indeterminate Potential in Non-ischemic Heart Failure With Reduced Ejection Fraction

Completed

Conditions: Heart Failure With Reduced Ejection Fraction

First Posted Date: 2023-08-08

Last Posted Date: 2023-11-13

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT05981144

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Phase 4

Recruiting

Conditions: Sodium-Glucose Transporter 2 Inhibitors
Diabetes Mellitus
Cellular Senescence

Interventions: Drug: Glimepiride
Drug: SGLT2 inhibitor

First Posted Date: 2023-08-04

Last Posted Date: 2024-05-09

Lead Sponsor: Yonsei University

Target Recruit Count: 92

Registration Number: NCT05975528

Locations: 🇰🇷
Yonsei University College of Medicine, Seoul, Korea, Republic of

The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era

Active, not recruiting

Conditions: Dilated Cardiomyopathy
Heart Failure, Reduced Ejection Fraction
Ventricular Remodeling

First Posted Date: 2023-08-03

Last Posted Date: 2023-08-03

Lead Sponsor: Yonsei University

Target Recruit Count: 500

Registration Number: NCT05973591

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic Steroids

Phase 4

Not yet recruiting

Conditions: Patients on Treatment With Systemic Steroids

Interventions: Drug: Fexuprazan Hydrochloride
Drug: Lansoprazole

First Posted Date: 2023-07-14

Last Posted Date: 2023-07-14

Lead Sponsor: Yonsei University

Target Recruit Count: 70

Registration Number: NCT05946135

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy